1.
89例患者的临床资料
Clinical data of the 89 patients
| Parameter | Non-healing or recurrent hyperthyroidism (n=27) | Premature hypothyroidism (n=50) | Euthyroidism or lost of follow-up (n=12) | P |
| ATD: Anti-thyroid drugs; SWE: Shear wave elastic velocity value; FT3: Free triiodothyronine; FT4: Free thyroxinef; TRAb: Thyrotrophin receptor antibody. | ||||
| Ki67 [n(%)] | 0.082 | |||
| Positive | 14 (0.23) | 37(0.61) | 10 (0.16) | |
| Negative | 13 (0.46) | 13(0.46) | 2(0.07) | |
| Gender [n(%)] | 0.787 | |||
| Male | 8 (0.36) | 11 (0.50) | 3 (0.14) | |
| Female | 19 (0.28) | 39 (0.58) | 9 (0.13) | |
| Age (Mean±SD) | 41.1±13.9 | 46.4±13.6 | 45.2±12.9 | 0.268 |
| Course of GD | 48.0 [12.0;60.0] | 12.5 [3.00;57.0] | 7.00 [4.75;24.2] | 0.098 |
| ATD history [n(%)] | 0.241 | |||
| No | 6 (0.22) | 15 (0.56) | 6 (0.22) | |
| Yes | 21 (0.34) | 35 (0.56) | 6 (0.10) | |
| Dose of 131I (Median[Q25, Q75]) | 6.20 [5.55;8.60] | 6.45 [5.03;7.95] | 6.45 [5.47;7.18] | 0.728 |
| Thyroid volume (Median[Q25, Q75]) | 23.6 [18.7;36.4] | 17.9 [13.5;23.5] | 18.2 [16.6;21.8] | 0.001 |
| SWE (Median[Q25, Q75]) | 1.64 [1.33;1.90] | 1.87 [1.65;2.07] | 1.79 [1.49;2.35] | 0.077 |
| FT3 (Median[Q25, Q75]) | 13.5 [9.28;27.9] | 16.8 [10.7;27.8] | 24.3 [10.8;29.2] | 0.794 |
| FT4 (Median[Q25, Q75]) | 36.3 [23.1;55.5] | 38.2 [27.7;53.3] | 49.2 [30.7;62.7] | 0.554 |
| TRAb (Median[Q25, Q75]) | 3.45 [1.74;9.59] | 13.8 [3.80;21.8] | 13.8 [4.07;18.3] | 0.035 |